Novartis initiate Clinical Trial Oral Parathyroid Hormone (PTH)

Novartis have initiated a Phase I of Oral Parathyroid Hormone (PTH) in postmenopausal women.The oral formulation was created using Emisphere’s proprietary Eligen technology.